About: Argenica Therapeutics Limited, a biotechnology company, engages in the research and development of neuroprotective therapeutic drugs in Australia. Its lead product candidate is ARG-007, a neuroprotective peptide candidate, which is in phase 2 clinical trial to reduce brain tissue death after stroke and other types of brain injury. Argenica Therapeutics Limited was incorporated in 2019 and is based in Nedlands, Australia.
Sector: Healthcare
Industry: Biotechnology
Latest price: A$0.18 (-2.78%)
AGNASXArgenica Therapeutics Ltd
Loading watchlist status…
Argenica Therapeutics Ltd share price
AGN price activity
Last Price
$0.180
Change (24hr)
-0.01 AUD (-2.78%)
Volume
39.50K
Volume (4w avg)
-
Open
$0.18
Day Range
$0.18 - $0.18
Previous Close
$0.18
Last Trade
07 Sep, 3:30 am GMT+0
Delayed
07 Sep, 3:30 am GMT+0
AGN price performance
-10.26%
5D
0%
1M
-40.68%
YTD
-30%
1Y
Delayed
07 Sep, 3:30 am GMT+0
AGN Market Signals